Pediatric Epilepsy Management: Special Considerations

Abstract

While pediatric epilepsy shares some features with adult epilepsy, the growing and developing brain during childhood is associated with differences in epilepsy etiologies, syndromes, comorbidities, management, and outcomes. We must also consider the long-term effects of epilepsy and treatments. This section highlights unique considerations for pediatric epilepsy. These include pediatric onset electroclinical syndromes that commonly resolve prior to adulthood, treatment duration of self-limited pediatric epilepsy syndromes, pediatric-onset epilepsy with etiology-specific treatment, and therapies used more commonly in the pediatric population. In addition, pediatric-onset epilepsy is associated with a higher risk for developmental, psychiatric, and behavioral comorbidities in a bidirectional fashion. Family dynamics are affected by a child with epilepsy, and transitioning to the adult clinic is a particular challenge for this population. Finally, there are special issues that occur in pediatric epilepsy, including the lack of pediatric FDA approvals for newly available therapies and the need for sedation for investigations.

Keywords

epilepsy - pediatric - comorbidities - electroclinical syndromes - antiseizure medications

Publikationsverlauf

Accepted Manuscript online:
04. Februar 2025

Artikel online veröffentlicht:
28. Februar 2025

• References

• 1 Wirrell EC, Grossardt BR, Wong-Kisiel LC, Nickels KC. Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: a population-based study. Epilepsy Res 2011; 95 (1-2): 110-118
• 2 Shellhaas RA, Wusthoff CJ, Tsuchida TN. et al. Neonatal Seizure Registry. Profile of neonatal epilepsies: characteristics of a prospective US cohort. Neurology 2017; 89 (09) 893-899
• 3 Zuberi SM, Wirrell E, Yozawitz E. et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia 2022; 63 (06) 1349-1397
• 4 Spoto G, Saia MC, Amore G. et al. Neonatal seizures: an overview of genetic causes and treatment options. Brain Sci 2021; 11 (10) 1295
• 5 Cornet MC, Morabito V, Lederer D. et al. Neonatal presentation of genetic epilepsies: early differentiation from acute provoked seizures. Epilepsia 2021; 62 (08) 1907-1920
• 6 Ziobro J, Shellhaas RA. Neonatal seizures: diagnosis, etiologies, and management. Semin Neurol 2020; 40 (02) 246-256
• 7 Espeche A. Benign infantile seizures: a prospective study. Epilepsy Res 2010; 89 (01) 96-103
• 8 Caraballo RH, Flesler S, Pasteris MC, Lopez Avaria MF, Fortini S, Vilte C. Myoclonic epilepsy in infancy: an electroclinical study and long-term follow-up of 38 patients. Epilepsia 2013; 54 (09) 1605-1612
• 9 Knupp KG, Coryell J, Nickels KC. et al. Pediatric Epilepsy Research Consortium. Response to treatment in a prospective national infantile spasms cohort. Ann Neurol 2016; 79 (03) 475-484
• 10 O'Callaghan FJ, Lux AL, Darke K. et al. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study. Epilepsia 2011; 52 (07) 1359-1364
• 11 Primec ZR, Stare J, Neubauer D. The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration. Epilepsia 2006; 47 (12) 2202-2205
• 12 Specchio N, Wirrell EC, Scheffer IE. et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia 2022; 63 (06) 1398-1442
• 13 Wickens S, Bowden SC, D'Souza W. Cognitive functioning in children with self-limited epilepsy with centrotemporal spikes: a systematic review and meta-analysis. Epilepsia 2017; 58 (10) 1673-1685
• 14 Camfield CS, Camfield PR. Rolandic epilepsy has little effect on adult life 30 years later: a population-based study. Neurology 2014; 82 (13) 1162-1166
• 15 CP. P. Panayiotopoulos Syndrome. London, UK: John Libbey and Company; 2002
• 16 Specchio N, Trivisano M, Di Ciommo V. et al. Panayiotopoulos syndrome: a clinical, EEG, and neuropsychological study of 93 consecutive patients. Epilepsia 2010; 51 (10) 2098-2107
• 17 Ferrie CD, Livingston JH. Panayiotopoulos syndrome: learning lessons from atypical cases. Epileptic Disord 2010; 12 (01) 92-94
• 18 Kelley SA, Kossoff EH. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol 2010; 52 (11) 988-993
• 19 Nickels K, Kossoff EH, Eschbach K, Joshi C. Epilepsy with myoclonic-atonic seizures (Doose syndrome): Clarification of diagnosis and treatment options through a large retrospective multicenter cohort. Epilepsia 2021; 62 (01) 120-127
• 20 Reed L, Ciliberto M, Fong SL. et al. Efficacy of felbamate in a cohort of patients with epilepsy with myoclonic atonic seizures (EMAtS). Epilepsy Res 2024; 201: 107314
• 21 Glauser TA, Cnaan A, Shinnar S. et al. Childhood Absence Epilepsy Study Team. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia 2013; 54 (01) 141-155
• 22 Masur D, Shinnar S, Cnaan A. et al. Childhood Absence Epilepsy Study Group. Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. Neurology 2013; 81 (18) 1572-1580
• 23 Berg AT, Levy SR, Testa FM, Blumenfeld H. Long-term seizure remission in childhood absence epilepsy: might initial treatment matter?. Epilepsia 2014; 55 (04) 551-557
• 24 Baumer FM, McNamara NA, Fine AL. et al. Treatment practices and outcomes in continuous spike and wave during slow wave sleep: a multicenter collaboration. J Pediatr 2021; 232: 220-228.e3
• 25 Nickels K, Wirrell E. Electrical status epilepticus in sleep. Semin Pediatr Neurol 2008; 15 (02) 50-60
• 26 Moosa ANV. Antiepileptic drug treatment of epilepsy in children. Continuum (Minneap Minn) 2019; 25 (02) 381-407
• 27 Camfield P, Camfield C. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy. Neurology 2005; 64 (06) 973-975
• 28 Latzer IT, Pearl PL. Treatable inherited metabolic epilepsies. Epilepsy Behav 2024; 151: 109621
• 29 Pearl PL. Amenable treatable severe pediatric epilepsies. Semin Pediatr Neurol 2016; 23 (02) 158-166
• 30 Wilder RM. The effect of ketonemia on the course of epilepsy. Mayo Clin Bulletin 1921; 2: 307-308
• 31 Kossoff EH, Zupec-Kania BA, Auvin S. et al. Charlie Foundation, Matthew's Friends, Practice Committee of the Child Neurology Society. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open 2018; 3 (02) 175-192
• 32 Husari KS, Cervenka MC. The ketogenic diet all grown up-ketogenic diet therapies for adults. Epilepsy Res 2020; 162: 106319
• 33 Ye F, Li XJ, Jiang WL, Sun HB, Liu J. Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. J Clin Neurol 2015; 11 (01) 26-31
• 34 Cervenka MC, Kossoff EH. Dietary treatment of intractable epilepsy. Continuum (Minneap Minn) 2013; 19 (3 epilepsy): 756-766
• 35 Sondhi V, Agarwala A, Pandey RM. et al. Efficacy of ketogenic diet, modified Atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: a randomized clinical trial. JAMA Pediatr 2020; 174 (10) 944-951
• 36 Berg AT, Zelko FA, Levy SR, Testa FM. Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes: a prospective cohort study. Neurology 2012; 79 (13) 1384-1391
• 37 Braun KPJ, Cross JH. Pediatric epilepsy surgery: the earlier the better. Expert Rev Neurother 2018; 18 (04) 261-263
• 38 Beatty CW, Lockrow JP, Gedela S, Gehred A, Ostendorf AP. The missed value of underutilizing pediatric epilepsy surgery: a systematic review. Semin Pediatr Neurol 2021; 39: 100917
• 39 Romanowski EF, McNamara N. Surgery for intractable epilepsy in pediatrics, a systematic review of outcomes other than seizure freedom. Semin Pediatr Neurol 2021; 39: 100928
• 40 Fisher RS, Acevedo C, Arzimanoglou A. et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55 (04) 475-482
• 41 Lukmanji S, Manji SA, Kadhim S. et al. The co-occurrence of epilepsy and autism: a systematic review. Epilepsy Behav 2019; 98 (Pt A): 238-248
• 42 Capal JK, Jeste SS. Autism and epilepsy. Pediatr Clin North Am 2024; 71 (02) 241-252
• 43 Berg AT, Plioplys S. Epilepsy and autism: is there a special relationship?. Epilepsy Behav 2012; 23 (03) 193-198
• 44 He Z, Yang X, Li Y, Zhao X, Li J, Li B. Attention-deficit/hyperactivity disorder in children with epilepsy: a systematic review and meta-analysis of prevalence and risk factors. Epilepsia Open 2024; 9 (04) 1148-1165
• 45 Mula M, Coleman H, Wilson SJ. Neuropsychiatric and cognitive comorbidities in epilepsy. Continuum (Minneap Minn) 2022; 28 (02) 457-482
• 46 Nobili L, Frauscher B, Eriksson S. et al. Sleep and epilepsy: a snapshot of knowledge and future research lines. J Sleep Res 2022; 31 (04) e13622
• 47 D'Onofrio G, Roberti R, Riva A. et al. Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric population. Neurotherapeutics 2024; 21 (03) e00344
• 48 Anderson LR, Yang C, Cotter JM. et al. School health: pediatric primary care curriculum. MedEdPORTAL 2018; 14: 10764
• 49 Berg AT, Kaiser K, Dixon-Salazar T. et al. Seizure burden in severe early-life epilepsy: perspectives from parents. Epilepsia Open 2019; 4 (02) 293-301
• 50 Uhl S, Konnyu K, Wilson R, Adam G, Robinson KA, Viswanathan M. Parent perceptions and decision making about treatments for epilepsy: a qualitative evidence synthesis. BMJ Open 2023; 13 (01) e066872
• 51 Muthiah N, Rothenberger S, Abel TJ. Socioeconomic status and healthcare utilization disparities among children with epilepsy in the United States: results from a nationally representative sample. Sci Rep 2023; 13 (01) 21776
• 52 Abildgaard Hansen O, Clemensen J, Beier CP, Barasinski Pedersen J, Smith AC, Kaas Larsen M. Living with epilepsy in adolescence and young adulthood transitioning from pediatric to adult hospital services: a systematic review and meta-synthesis of qualitative studies. Epilepsy Behav 2024; 158: 109955
• 53 Pieters H, Watson M, Baca CM. Pediatric and adult epileptologist perspectives and experiences of pediatric to adult epilepsy care transition: “saying goodbye and opening a door.”. Epilepsy Behav 2021; 120: 107981
• 54 Andrade DM, Bassett AS, Bercovici E. et al. Epilepsy: transition from pediatric to adult care. Recommendations of the Ontario epilepsy implementation task force. Epilepsia 2017; 58 (09) 1502-1517
• 55 Camfield PR, Gibson PA, Douglass LM. Strategies for transitioning to adult care for youth with Lennox-Gastaut syndrome and related disorders. Epilepsia 2011; 52 (Suppl. 05) 21-27
• 56 Pellock JM, Arzimanoglou A, D'Cruz O, Holmes GL, Nordli D, Shinnar S. Pediatric Epilepsy Academic Consortium for Extrapolation. Extrapolating evidence of antiepileptic drug efficacy in adults to children ≥2 years of age with focal seizures: The case for disease similarity. Epilepsia 2017; 58 (10) 1686-1696
• 57 French JA, Cleary E, Dlugos D. et al. Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 years. Epilepsia 2022; 63 (10) 2664-2670
• 58 Romito B, Jewell J, Jackson M. AAP Committee on Hospital Care; Association of Child Life Professionals. Child life services. Pediatrics 2021; 147 (01) e2020040261
• 59 Maglalang PD, Sinha J, Zimmerman K. et al. Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee. Application of physiologically based pharmacokinetic modeling to characterize the effects of age and obesity on the disposition of levetiracetam in the pediatric population. Clin Pharmacokinet 2024; 63 (06) 885-899